Ferroudj et al. found that BRCA1 and BRCA2 expression levels display a gradual increase in parallel in tumor progression from early to advanced stages of hepatocellular carcinoma (HCC) by utilizing human hepatocellular carcinoma microarrays in the Gene Expression Omnibus database [33]. This evidence concerns the gene BRCA2 and hepatocellular carcinoma.